Dose-Response Characteristics of Spinal Bupivacaine in Volunteers
- 1 October 1996
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 85 (4), 729-736
- https://doi.org/10.1097/00000542-199610000-00007
Abstract
Background Small doses of bupivacaine may be a reasonable choice for spinal anesthesia for patients having ambulatory surgery. However, few dose-response data are available to guide the selection of reasonable doses of bupivacaine for different ambulatory procedures. Methods Eight volunteers per group were randomized to receive 3.75, 7.5, or 11.25 mg of 0.75% bupivacaine with 8.25% dextrose in a double-blind manner. Sensory block was assessed with pinprick, transcutaneous electrical stimulation equivalent to surgical incision at the ankle, knee, pubis, and umbilicus, and with duration of tolerance to pneumatic thigh tourniquet. Motor block at the quadriceps and gastrocnemius muscles was assessed with isometric force dynamometry. Times until recovery from spinal anesthesia were recorded. Dose-response relationships were determined by linear regressions. Mean (95% confidence intervals) for durations of sensory and motor block per milligram of bupivacaine administered were calculated from linear regressions. Results Significant dose-response relationships (P < 0.006) were determined for sensory block, motor block, and time until recovery (R from 0.6 to 0.9). Within the range of doses studied, each additional milligram of bupivacaine was associated with an increase in duration of tolerance to transcutaneous electrical stimulation of 10 (7 to 13) min, an increase in tolerance to tourniquet of 7 (2 to 11) min, an increase in duration of motor block of 8 (5 to 12) min, and an increase in time until recovery of 21 (17 to 25) min. Conclusions These dose-response data may guide the selection of reasonable doses of bupivacaine for various outpatient procedures, although individual responses vary.Keywords
This publication has 25 references indexed in Scilit:
- Transient Neurologic Symptoms After Spinal AnesthesiaAnesthesia & Analgesia, 1995
- Hyperbaric Lidocaine Spinal AnesthesiaAnesthesia & Analgesia, 1995
- Comparison of 5% with Dextrose, 1.5% with Dextrose, and 1.5% Dextrose-Free Lidocaine Solutions for Spinal Anesthesia in Human VolunteersAnesthesia & Analgesia, 1995
- Transient Neurologic Deficit After Spinal AnesthesiaAnesthesia & Analgesia, 1995
- Spinal Anesthesia in Outpatient Knee SurgeryAnesthesia & Analgesia, 1995
- Concentration Dependence of Lidocaine-induced Irreversible Conduction Loss in Frog NerveAnesthesiology, 1994
- Irreversible Conduction Block in Isolated Nerve by High Concentrations of Local AnestheticsAnesthesiology, 1994
- Persistent Sacral Sensory Deficit Induced by Intrathecal Local Anesthetic Infusion in the RatAnesthesiology, 1994
- Transient Neurologic Toxicity After Hyperbaric Subarachnoid Anesthesia with 5% LidocaineAnesthesia & Analgesia, 1993
- SPINAL ANALGESIA WITH HYPERBARIC BUPIVACAINE: EFFECTS OF VOLUME OF SOLUTIONBritish Journal of Anaesthesia, 1982